Oral Presentation—IO-202, A Novel Anti-LILRB4 Antibody, with Azacitidine for Hypomethylating Agent-Naive Chronic Myelomonocytic Leukemia: Phase 1b Expansion Cohort Results Dec 9 Written By Vikki Christian Mannis G, et al. 66th ASH Annual Meeting and Exposition, December 7-10, 2024. Vikki Christian
Oral Presentation—IO-202, A Novel Anti-LILRB4 Antibody, with Azacitidine for Hypomethylating Agent-Naive Chronic Myelomonocytic Leukemia: Phase 1b Expansion Cohort Results Dec 9 Written By Vikki Christian Mannis G, et al. 66th ASH Annual Meeting and Exposition, December 7-10, 2024. Vikki Christian
